Telix Pharmaceuticals Limited (ASX:TLX)
Australia flag Australia · Delayed Price · Currency is AUD
18.33
+0.23 (1.27%)
Aug 22, 2025, 4:13 PM AEST

Telix Pharmaceuticals Ratios and Metrics

Millions AUD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
6,2038,2383,2632,3002,2091,060
Upgrade
Market Cap Growth
32.56%152.44%41.89%4.10%108.44%169.99%
Upgrade
Enterprise Value
6,5258,1413,1452,1802,1611,039
Upgrade
Last Close Price
18.3324.6110.087.277.753.78
Upgrade
PE Ratio
281.83165.02626.21---
Upgrade
Forward PE
118.1187.2732.83---
Upgrade
PS Ratio
6.1210.526.4914.37290.85203.33
Upgrade
PB Ratio
9.6414.5021.9128.751023.7813.41
Upgrade
P/TBV Ratio
-54.1783.14109.40-53.46
Upgrade
P/FCF Ratio
422.00286.95229.72--619.12
Upgrade
P/OCF Ratio
179.72191.44136.63--540.78
Upgrade
EV/Sales Ratio
6.4410.396.2613.62284.54199.24
Upgrade
EV/EBITDA Ratio
106.5892.9555.00---
Upgrade
EV/EBIT Ratio
152.2599.4160.60---
Upgrade
EV/FCF Ratio
443.91283.58221.37--606.68
Upgrade
Debt / Equity Ratio
0.991.020.120.131.180.03
Upgrade
Debt / EBITDA Ratio
10.426.470.30---
Upgrade
Debt / FCF Ratio
43.4020.261.23--1.29
Upgrade
Asset Turnover
0.790.821.520.880.060.04
Upgrade
Inventory Turnover
10.9710.7915.3610.921.253.45
Upgrade
Quick Ratio
1.112.601.181.901.134.62
Upgrade
Current Ratio
1.332.781.412.031.254.69
Upgrade
Return on Equity (ROE)
3.14%13.92%4.55%-253.34%-198.36%-60.21%
Upgrade
Return on Assets (ROA)
2.08%5.33%9.81%-25.37%-37.95%-23.64%
Upgrade
Return on Capital (ROIC)
3.12%7.78%25.26%-97.35%-118.20%-40.13%
Upgrade
Return on Capital Employed (ROCE)
3.20%6.90%21.50%---
Upgrade
Earnings Yield
0.27%0.61%0.16%-4.53%-3.64%-4.23%
Upgrade
FCF Yield
0.24%0.35%0.43%-3.09%-2.75%0.16%
Upgrade
Buyback Yield / Dilution
37.99%-6.64%-4.21%-10.08%-9.69%-10.21%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.